IMO it has one of two possibilities. Either the coverage was impacted by lack of a business deal if PJ is really off the radar which means nothing to the science or trials. Second could be that there is an error on reporting the facts if coverage was dropped (human error).
Either way this should only impact the weak hands if at all. As the couch says "24 months in" NEXT.
PJ dropped another stock I owned about 7 years ago and we thought the worst then too but it ended up being that the analyst covering the stock for them quit and went to another firm.
Market Data 
Markets 
AI
